nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—ESR2—osteoporosis	0.175	0.438	CbGaD
Raloxifene—CYP19A1—osteoporosis	0.117	0.293	CbGaD
Raloxifene—ESR1—osteoporosis	0.108	0.27	CbGaD
Raloxifene—ESR2—Estropipate—osteoporosis	0.0847	0.184	CbGbCtD
Raloxifene—ESR2—Ethinyl Estradiol—osteoporosis	0.0546	0.119	CbGbCtD
Raloxifene—AOX1—Ethinyl Estradiol—osteoporosis	0.0487	0.106	CbGbCtD
Raloxifene—ESR1—Estropipate—osteoporosis	0.0434	0.0943	CbGbCtD
Raloxifene—ESR2—Conjugated Estrogens—osteoporosis	0.0401	0.0871	CbGbCtD
Raloxifene—ESR2—Estradiol—osteoporosis	0.0352	0.0764	CbGbCtD
Raloxifene—AOX1—Estradiol—osteoporosis	0.0314	0.0682	CbGbCtD
Raloxifene—ESR1—Ethinyl Estradiol—osteoporosis	0.028	0.0608	CbGbCtD
Raloxifene—ESR1—Conjugated Estrogens—osteoporosis	0.0205	0.0446	CbGbCtD
Raloxifene—ESR1—Estradiol—osteoporosis	0.018	0.0392	CbGbCtD
Raloxifene—CYP2B6—Ethinyl Estradiol—osteoporosis	0.00935	0.0203	CbGbCtD
Raloxifene—CYP2B6—Cholecalciferol—osteoporosis	0.00748	0.0162	CbGbCtD
Raloxifene—CYP2C8—Ethinyl Estradiol—osteoporosis	0.00708	0.0154	CbGbCtD
Raloxifene—CYP2C8—Cholecalciferol—osteoporosis	0.00566	0.0123	CbGbCtD
Raloxifene—CYP2C8—Estradiol—osteoporosis	0.00456	0.00992	CbGbCtD
Raloxifene—CYP3A4—Estropipate—osteoporosis	0.00446	0.00968	CbGbCtD
Raloxifene—CYP3A4—Calcitriol—osteoporosis	0.00446	0.00968	CbGbCtD
Raloxifene—CYP3A4—Ergocalciferol—osteoporosis	0.00356	0.00774	CbGbCtD
Raloxifene—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00287	0.00624	CbGbCtD
Raloxifene—CYP3A4—Cholecalciferol—osteoporosis	0.0023	0.00499	CbGbCtD
Raloxifene—CYP3A4—Conjugated Estrogens—osteoporosis	0.00211	0.00458	CbGbCtD
Raloxifene—CYP3A4—Estradiol—osteoporosis	0.00185	0.00402	CbGbCtD
Raloxifene—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000873	1	CbGdCrCtD
Raloxifene—Influenza—Estradiol—osteoporosis	0.000132	0.00118	CcSEcCtD
Raloxifene—Hyperhidrosis—Ibandronate—osteoporosis	0.000131	0.00117	CcSEcCtD
Raloxifene—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.000131	0.00117	CcSEcCtD
Raloxifene—Nausea—Ergocalciferol—osteoporosis	0.000131	0.00117	CcSEcCtD
Raloxifene—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000131	0.00117	CcSEcCtD
Raloxifene—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00013	0.00116	CcSEcCtD
Raloxifene—Abdominal pain—Etidronic acid—osteoporosis	0.000129	0.00115	CcSEcCtD
Raloxifene—Skin disorder—Calcitriol—osteoporosis	0.000129	0.00115	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000129	0.00115	CcSEcCtD
Raloxifene—Insomnia—Estropipate—osteoporosis	0.000128	0.00114	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000127	0.00113	CcSEcCtD
Raloxifene—Cardiac disorder—Zoledronate—osteoporosis	0.000127	0.00113	CcSEcCtD
Raloxifene—Flushing—Zoledronate—osteoporosis	0.000127	0.00113	CcSEcCtD
Raloxifene—Bronchitis—Estradiol—osteoporosis	0.000127	0.00113	CcSEcCtD
Raloxifene—Muscle spasms—Pamidronate—osteoporosis	0.000125	0.00112	CcSEcCtD
Raloxifene—Dyspepsia—Estropipate—osteoporosis	0.000125	0.00111	CcSEcCtD
Raloxifene—Angiopathy—Zoledronate—osteoporosis	0.000124	0.00111	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.000124	0.0011	CcSEcCtD
Raloxifene—Vertigo—Risedronate—osteoporosis	0.000123	0.0011	CcSEcCtD
Raloxifene—Syncope—Risedronate—osteoporosis	0.000123	0.0011	CcSEcCtD
Raloxifene—Insomnia—Ibandronate—osteoporosis	0.000123	0.0011	CcSEcCtD
Raloxifene—Dyspepsia—Alendronate—osteoporosis	0.000123	0.0011	CcSEcCtD
Raloxifene—Cough—Ethinyl Estradiol—osteoporosis	0.000123	0.0011	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Estropipate—osteoporosis	0.000122	0.00109	CcSEcCtD
Raloxifene—Cardiac disorder—Conjugated Estrogens—osteoporosis	0.000122	0.00109	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000121	0.00108	CcSEcCtD
Raloxifene—Pain—Estropipate—osteoporosis	0.000121	0.00108	CcSEcCtD
Raloxifene—Loss of consciousness—Risedronate—osteoporosis	0.00012	0.00108	CcSEcCtD
Raloxifene—Insomnia—Calcitriol—osteoporosis	0.00012	0.00107	CcSEcCtD
Raloxifene—Weight increased—Estradiol—osteoporosis	0.00012	0.00107	CcSEcCtD
Raloxifene—Cough—Risedronate—osteoporosis	0.00012	0.00107	CcSEcCtD
Raloxifene—Dyspepsia—Ibandronate—osteoporosis	0.00012	0.00107	CcSEcCtD
Raloxifene—Angiopathy—Conjugated Estrogens—osteoporosis	0.000119	0.00107	CcSEcCtD
Raloxifene—Pain—Alendronate—osteoporosis	0.000119	0.00106	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000119	0.00106	CcSEcCtD
Raloxifene—Pneumonia—Estradiol—osteoporosis	0.000118	0.00105	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000117	0.00105	CcSEcCtD
Raloxifene—Depression—Estradiol—osteoporosis	0.000117	0.00104	CcSEcCtD
Raloxifene—Syncope—Pamidronate—osteoporosis	0.000117	0.00104	CcSEcCtD
Raloxifene—Myalgia—Risedronate—osteoporosis	0.000117	0.00104	CcSEcCtD
Raloxifene—Arthralgia—Risedronate—osteoporosis	0.000117	0.00104	CcSEcCtD
Raloxifene—Chest pain—Risedronate—osteoporosis	0.000117	0.00104	CcSEcCtD
Raloxifene—Pain—Ibandronate—osteoporosis	0.000116	0.00104	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000116	0.00103	CcSEcCtD
Raloxifene—Gastrointestinal pain—Estropipate—osteoporosis	0.000116	0.00103	CcSEcCtD
Raloxifene—Loss of consciousness—Pamidronate—osteoporosis	0.000115	0.00102	CcSEcCtD
Raloxifene—Muscle spasms—Zoledronate—osteoporosis	0.000114	0.00102	CcSEcCtD
Raloxifene—Conjunctivitis—Estradiol—osteoporosis	0.000114	0.00102	CcSEcCtD
Raloxifene—Urinary tract infection—Estradiol—osteoporosis	0.000114	0.00102	CcSEcCtD
Raloxifene—Gastrointestinal pain—Alendronate—osteoporosis	0.000114	0.00102	CcSEcCtD
Raloxifene—Infection—Ethinyl Estradiol—osteoporosis	0.000114	0.00102	CcSEcCtD
Raloxifene—Cough—Pamidronate—osteoporosis	0.000114	0.00102	CcSEcCtD
Raloxifene—Pain—Calcitriol—osteoporosis	0.000114	0.00101	CcSEcCtD
Raloxifene—Flatulence—Conjugated Estrogens—osteoporosis	0.000113	0.00101	CcSEcCtD
Raloxifene—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000113	0.001	CcSEcCtD
Raloxifene—Diarrhoea—Etidronic acid—osteoporosis	0.000112	0.001	CcSEcCtD
Raloxifene—Body temperature increased—Estropipate—osteoporosis	0.000112	0.000999	CcSEcCtD
Raloxifene—Abdominal pain—Estropipate—osteoporosis	0.000112	0.000999	CcSEcCtD
Raloxifene—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000111	0.000995	CcSEcCtD
Raloxifene—Infection—Risedronate—osteoporosis	0.000111	0.000992	CcSEcCtD
Raloxifene—Gastrointestinal pain—Ibandronate—osteoporosis	0.000111	0.000991	CcSEcCtD
Raloxifene—Arthralgia—Pamidronate—osteoporosis	0.000111	0.00099	CcSEcCtD
Raloxifene—Myalgia—Pamidronate—osteoporosis	0.000111	0.00099	CcSEcCtD
Raloxifene—Body temperature increased—Alendronate—osteoporosis	0.00011	0.000984	CcSEcCtD
Raloxifene—Abdominal pain—Alendronate—osteoporosis	0.00011	0.000984	CcSEcCtD
Raloxifene—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00011	0.000984	CcSEcCtD
Raloxifene—Sinusitis—Estradiol—osteoporosis	0.00011	0.000983	CcSEcCtD
Raloxifene—Shock—Risedronate—osteoporosis	0.00011	0.000983	CcSEcCtD
Raloxifene—Nervous system disorder—Risedronate—osteoporosis	0.00011	0.00098	CcSEcCtD
Raloxifene—Skin disorder—Risedronate—osteoporosis	0.000109	0.00097	CcSEcCtD
Raloxifene—Gastrointestinal pain—Calcitriol—osteoporosis	0.000109	0.00097	CcSEcCtD
Raloxifene—Abdominal pain—Ibandronate—osteoporosis	0.000107	0.000958	CcSEcCtD
Raloxifene—Body temperature increased—Ibandronate—osteoporosis	0.000107	0.000958	CcSEcCtD
Raloxifene—Vertigo—Zoledronate—osteoporosis	0.000107	0.000955	CcSEcCtD
Raloxifene—Syncope—Zoledronate—osteoporosis	0.000107	0.000953	CcSEcCtD
Raloxifene—Infection—Pamidronate—osteoporosis	0.000106	0.000943	CcSEcCtD
Raloxifene—Rhinitis—Estradiol—osteoporosis	0.000106	0.000943	CcSEcCtD
Raloxifene—Abdominal pain—Calcitriol—osteoporosis	0.000105	0.000938	CcSEcCtD
Raloxifene—Body temperature increased—Calcitriol—osteoporosis	0.000105	0.000938	CcSEcCtD
Raloxifene—Hypoaesthesia—Estradiol—osteoporosis	0.000105	0.000936	CcSEcCtD
Raloxifene—Shock—Pamidronate—osteoporosis	0.000105	0.000934	CcSEcCtD
Raloxifene—Loss of consciousness—Zoledronate—osteoporosis	0.000105	0.000934	CcSEcCtD
Raloxifene—Pharyngitis—Estradiol—osteoporosis	0.000105	0.000934	CcSEcCtD
Raloxifene—Nervous system disorder—Pamidronate—osteoporosis	0.000104	0.000931	CcSEcCtD
Raloxifene—Thrombocytopenia—Pamidronate—osteoporosis	0.000104	0.00093	CcSEcCtD
Raloxifene—Urinary tract disorder—Estradiol—osteoporosis	0.000104	0.000929	CcSEcCtD
Raloxifene—Vomiting—Etidronic acid—osteoporosis	0.000104	0.000929	CcSEcCtD
Raloxifene—Cough—Zoledronate—osteoporosis	0.000104	0.000927	CcSEcCtD
Raloxifene—Oedema peripheral—Estradiol—osteoporosis	0.000104	0.000927	CcSEcCtD
Raloxifene—Connective tissue disorder—Estradiol—osteoporosis	0.000104	0.000924	CcSEcCtD
Raloxifene—Urethral disorder—Estradiol—osteoporosis	0.000103	0.000922	CcSEcCtD
Raloxifene—Rash—Etidronic acid—osteoporosis	0.000103	0.000921	CcSEcCtD
Raloxifene—Dermatitis—Etidronic acid—osteoporosis	0.000103	0.00092	CcSEcCtD
Raloxifene—Vertigo—Conjugated Estrogens—osteoporosis	0.000103	0.000919	CcSEcCtD
Raloxifene—Hyperhidrosis—Pamidronate—osteoporosis	0.000103	0.000918	CcSEcCtD
Raloxifene—Syncope—Conjugated Estrogens—osteoporosis	0.000103	0.000918	CcSEcCtD
Raloxifene—Headache—Etidronic acid—osteoporosis	0.000103	0.000915	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000102	0.00091	CcSEcCtD
Raloxifene—Arthralgia—Zoledronate—osteoporosis	0.000101	0.000905	CcSEcCtD
Raloxifene—Chest pain—Zoledronate—osteoporosis	0.000101	0.000905	CcSEcCtD
Raloxifene—Myalgia—Zoledronate—osteoporosis	0.000101	0.000905	CcSEcCtD
Raloxifene—Insomnia—Risedronate—osteoporosis	0.000101	0.000903	CcSEcCtD
Raloxifene—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000101	0.000899	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000101	0.000899	CcSEcCtD
Raloxifene—Cough—Conjugated Estrogens—osteoporosis	0.0001	0.000893	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	9.91e-05	0.000884	CcSEcCtD
Raloxifene—Dyspepsia—Risedronate—osteoporosis	9.85e-05	0.000879	CcSEcCtD
Raloxifene—Flushing—Estradiol—osteoporosis	9.78e-05	0.000873	CcSEcCtD
Raloxifene—Cardiac disorder—Estradiol—osteoporosis	9.78e-05	0.000873	CcSEcCtD
Raloxifene—Myalgia—Conjugated Estrogens—osteoporosis	9.76e-05	0.000871	CcSEcCtD
Raloxifene—Arthralgia—Conjugated Estrogens—osteoporosis	9.76e-05	0.000871	CcSEcCtD
Raloxifene—Chest pain—Conjugated Estrogens—osteoporosis	9.76e-05	0.000871	CcSEcCtD
Raloxifene—Nausea—Etidronic acid—osteoporosis	9.72e-05	0.000868	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	9.69e-05	0.000865	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Pamidronate—osteoporosis	9.69e-05	0.000865	CcSEcCtD
Raloxifene—Diarrhoea—Estropipate—osteoporosis	9.69e-05	0.000865	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Risedronate—osteoporosis	9.66e-05	0.000862	CcSEcCtD
Raloxifene—Infection—Zoledronate—osteoporosis	9.65e-05	0.000862	CcSEcCtD
Raloxifene—Insomnia—Pamidronate—osteoporosis	9.62e-05	0.000859	CcSEcCtD
Raloxifene—Pain—Risedronate—osteoporosis	9.57e-05	0.000854	CcSEcCtD
Raloxifene—Angiopathy—Estradiol—osteoporosis	9.56e-05	0.000854	CcSEcCtD
Raloxifene—Shock—Zoledronate—osteoporosis	9.56e-05	0.000853	CcSEcCtD
Raloxifene—Diarrhoea—Alendronate—osteoporosis	9.54e-05	0.000852	CcSEcCtD
Raloxifene—Nervous system disorder—Zoledronate—osteoporosis	9.53e-05	0.000851	CcSEcCtD
Raloxifene—Thrombocytopenia—Zoledronate—osteoporosis	9.51e-05	0.000849	CcSEcCtD
Raloxifene—Skin disorder—Zoledronate—osteoporosis	9.44e-05	0.000842	CcSEcCtD
Raloxifene—Hyperhidrosis—Zoledronate—osteoporosis	9.39e-05	0.000838	CcSEcCtD
Raloxifene—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	9.38e-05	0.000838	CcSEcCtD
Raloxifene—Dyspepsia—Pamidronate—osteoporosis	9.36e-05	0.000836	CcSEcCtD
Raloxifene—Dizziness—Estropipate—osteoporosis	9.36e-05	0.000836	CcSEcCtD
Raloxifene—Infection—Conjugated Estrogens—osteoporosis	9.29e-05	0.00083	CcSEcCtD
Raloxifene—Diarrhoea—Ibandronate—osteoporosis	9.29e-05	0.000829	CcSEcCtD
Raloxifene—Dizziness—Alendronate—osteoporosis	9.22e-05	0.000823	CcSEcCtD
Raloxifene—Shock—Conjugated Estrogens—osteoporosis	9.2e-05	0.000822	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Pamidronate—osteoporosis	9.18e-05	0.00082	CcSEcCtD
Raloxifene—Nervous system disorder—Conjugated Estrogens—osteoporosis	9.17e-05	0.000819	CcSEcCtD
Raloxifene—Gastrointestinal pain—Risedronate—osteoporosis	9.15e-05	0.000817	CcSEcCtD
Raloxifene—Pain—Pamidronate—osteoporosis	9.09e-05	0.000812	CcSEcCtD
Raloxifene—Diarrhoea—Calcitriol—osteoporosis	9.09e-05	0.000812	CcSEcCtD
Raloxifene—Skin disorder—Conjugated Estrogens—osteoporosis	9.09e-05	0.000811	CcSEcCtD
Raloxifene—Abdominal pain—Ethinyl Estradiol—osteoporosis	9.07e-05	0.00081	CcSEcCtD
Raloxifene—Body temperature increased—Ethinyl Estradiol—osteoporosis	9.07e-05	0.00081	CcSEcCtD
Raloxifene—Hyperhidrosis—Conjugated Estrogens—osteoporosis	9.04e-05	0.000807	CcSEcCtD
Raloxifene—Flatulence—Estradiol—osteoporosis	9.04e-05	0.000807	CcSEcCtD
Raloxifene—Vomiting—Estropipate—osteoporosis	9e-05	0.000804	CcSEcCtD
Raloxifene—Dizziness—Ibandronate—osteoporosis	8.98e-05	0.000801	CcSEcCtD
Raloxifene—Rash—Estropipate—osteoporosis	8.93e-05	0.000797	CcSEcCtD
Raloxifene—Dermatitis—Estropipate—osteoporosis	8.92e-05	0.000796	CcSEcCtD
Raloxifene—Headache—Estropipate—osteoporosis	8.87e-05	0.000792	CcSEcCtD
Raloxifene—Vomiting—Alendronate—osteoporosis	8.87e-05	0.000791	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Zoledronate—osteoporosis	8.85e-05	0.00079	CcSEcCtD
Raloxifene—Abdominal pain—Risedronate—osteoporosis	8.84e-05	0.00079	CcSEcCtD
Raloxifene—Body temperature increased—Risedronate—osteoporosis	8.84e-05	0.00079	CcSEcCtD
Raloxifene—Muscle spasms—Estradiol—osteoporosis	8.82e-05	0.000787	CcSEcCtD
Raloxifene—Rash—Alendronate—osteoporosis	8.79e-05	0.000785	CcSEcCtD
Raloxifene—Insomnia—Zoledronate—osteoporosis	8.79e-05	0.000784	CcSEcCtD
Raloxifene—Dermatitis—Alendronate—osteoporosis	8.78e-05	0.000784	CcSEcCtD
Raloxifene—Headache—Alendronate—osteoporosis	8.74e-05	0.00078	CcSEcCtD
Raloxifene—Gastrointestinal pain—Pamidronate—osteoporosis	8.7e-05	0.000776	CcSEcCtD
Raloxifene—Vomiting—Ibandronate—osteoporosis	8.63e-05	0.000771	CcSEcCtD
Raloxifene—Rash—Ibandronate—osteoporosis	8.56e-05	0.000764	CcSEcCtD
Raloxifene—Dermatitis—Ibandronate—osteoporosis	8.55e-05	0.000763	CcSEcCtD
Raloxifene—Dyspepsia—Zoledronate—osteoporosis	8.55e-05	0.000763	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.52e-05	0.000761	CcSEcCtD
Raloxifene—Headache—Ibandronate—osteoporosis	8.5e-05	0.000759	CcSEcCtD
Raloxifene—Insomnia—Conjugated Estrogens—osteoporosis	8.46e-05	0.000755	CcSEcCtD
Raloxifene—Vomiting—Calcitriol—osteoporosis	8.45e-05	0.000754	CcSEcCtD
Raloxifene—Nausea—Estropipate—osteoporosis	8.41e-05	0.000751	CcSEcCtD
Raloxifene—Body temperature increased—Pamidronate—osteoporosis	8.41e-05	0.000751	CcSEcCtD
Raloxifene—Abdominal pain—Pamidronate—osteoporosis	8.41e-05	0.000751	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Zoledronate—osteoporosis	8.39e-05	0.000749	CcSEcCtD
Raloxifene—Rash—Calcitriol—osteoporosis	8.38e-05	0.000748	CcSEcCtD
Raloxifene—Dermatitis—Calcitriol—osteoporosis	8.37e-05	0.000747	CcSEcCtD
Raloxifene—Headache—Calcitriol—osteoporosis	8.33e-05	0.000743	CcSEcCtD
Raloxifene—Pain—Zoledronate—osteoporosis	8.31e-05	0.000742	CcSEcCtD
Raloxifene—Nausea—Alendronate—osteoporosis	8.28e-05	0.000739	CcSEcCtD
Raloxifene—Vertigo—Estradiol—osteoporosis	8.24e-05	0.000736	CcSEcCtD
Raloxifene—Dyspepsia—Conjugated Estrogens—osteoporosis	8.23e-05	0.000735	CcSEcCtD
Raloxifene—Syncope—Estradiol—osteoporosis	8.23e-05	0.000734	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	8.08e-05	0.000721	CcSEcCtD
Raloxifene—Nausea—Ibandronate—osteoporosis	8.06e-05	0.00072	CcSEcCtD
Raloxifene—Loss of consciousness—Estradiol—osteoporosis	8.06e-05	0.00072	CcSEcCtD
Raloxifene—Cough—Estradiol—osteoporosis	8e-05	0.000715	CcSEcCtD
Raloxifene—Pain—Conjugated Estrogens—osteoporosis	8e-05	0.000714	CcSEcCtD
Raloxifene—Gastrointestinal pain—Zoledronate—osteoporosis	7.94e-05	0.000709	CcSEcCtD
Raloxifene—Nausea—Calcitriol—osteoporosis	7.89e-05	0.000705	CcSEcCtD
Raloxifene—Diarrhoea—Ethinyl Estradiol—osteoporosis	7.85e-05	0.000701	CcSEcCtD
Raloxifene—Arthralgia—Estradiol—osteoporosis	7.81e-05	0.000697	CcSEcCtD
Raloxifene—Myalgia—Estradiol—osteoporosis	7.81e-05	0.000697	CcSEcCtD
Raloxifene—Chest pain—Estradiol—osteoporosis	7.81e-05	0.000697	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	7.76e-05	0.000692	CcSEcCtD
Raloxifene—Abdominal pain—Zoledronate—osteoporosis	7.68e-05	0.000686	CcSEcCtD
Raloxifene—Body temperature increased—Zoledronate—osteoporosis	7.68e-05	0.000686	CcSEcCtD
Raloxifene—Diarrhoea—Risedronate—osteoporosis	7.65e-05	0.000683	CcSEcCtD
Raloxifene—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.65e-05	0.000683	CcSEcCtD
Raloxifene—Dizziness—Ethinyl Estradiol—osteoporosis	7.59e-05	0.000677	CcSEcCtD
Raloxifene—Infection—Estradiol—osteoporosis	7.44e-05	0.000664	CcSEcCtD
Raloxifene—Dizziness—Risedronate—osteoporosis	7.4e-05	0.000661	CcSEcCtD
Raloxifene—Abdominal pain—Conjugated Estrogens—osteoporosis	7.39e-05	0.00066	CcSEcCtD
Raloxifene—Body temperature increased—Conjugated Estrogens—osteoporosis	7.39e-05	0.00066	CcSEcCtD
Raloxifene—Shock—Estradiol—osteoporosis	7.37e-05	0.000658	CcSEcCtD
Raloxifene—Nervous system disorder—Estradiol—osteoporosis	7.34e-05	0.000655	CcSEcCtD
Raloxifene—Vomiting—Ethinyl Estradiol—osteoporosis	7.3e-05	0.000651	CcSEcCtD
Raloxifene—Diarrhoea—Pamidronate—osteoporosis	7.28e-05	0.00065	CcSEcCtD
Raloxifene—Skin disorder—Estradiol—osteoporosis	7.27e-05	0.000649	CcSEcCtD
Raloxifene—Hyperhidrosis—Estradiol—osteoporosis	7.24e-05	0.000646	CcSEcCtD
Raloxifene—Rash—Ethinyl Estradiol—osteoporosis	7.24e-05	0.000646	CcSEcCtD
Raloxifene—Dermatitis—Ethinyl Estradiol—osteoporosis	7.23e-05	0.000645	CcSEcCtD
Raloxifene—Headache—Ethinyl Estradiol—osteoporosis	7.19e-05	0.000642	CcSEcCtD
Raloxifene—Vomiting—Risedronate—osteoporosis	7.11e-05	0.000635	CcSEcCtD
Raloxifene—Rash—Risedronate—osteoporosis	7.05e-05	0.00063	CcSEcCtD
Raloxifene—Dermatitis—Risedronate—osteoporosis	7.05e-05	0.000629	CcSEcCtD
Raloxifene—Dizziness—Pamidronate—osteoporosis	7.03e-05	0.000628	CcSEcCtD
Raloxifene—Headache—Risedronate—osteoporosis	7.01e-05	0.000626	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Estradiol—osteoporosis	6.82e-05	0.000609	CcSEcCtD
Raloxifene—Nausea—Ethinyl Estradiol—osteoporosis	6.82e-05	0.000609	CcSEcCtD
Raloxifene—Insomnia—Estradiol—osteoporosis	6.77e-05	0.000605	CcSEcCtD
Raloxifene—Vomiting—Pamidronate—osteoporosis	6.76e-05	0.000604	CcSEcCtD
Raloxifene—Rash—Pamidronate—osteoporosis	6.71e-05	0.000599	CcSEcCtD
Raloxifene—Dermatitis—Pamidronate—osteoporosis	6.7e-05	0.000598	CcSEcCtD
Raloxifene—Headache—Pamidronate—osteoporosis	6.66e-05	0.000595	CcSEcCtD
Raloxifene—Diarrhoea—Zoledronate—osteoporosis	6.65e-05	0.000593	CcSEcCtD
Raloxifene—Nausea—Risedronate—osteoporosis	6.65e-05	0.000593	CcSEcCtD
Raloxifene—Dyspepsia—Estradiol—osteoporosis	6.59e-05	0.000588	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Estradiol—osteoporosis	6.46e-05	0.000577	CcSEcCtD
Raloxifene—Dizziness—Zoledronate—osteoporosis	6.42e-05	0.000574	CcSEcCtD
Raloxifene—Pain—Estradiol—osteoporosis	6.4e-05	0.000572	CcSEcCtD
Raloxifene—Diarrhoea—Conjugated Estrogens—osteoporosis	6.4e-05	0.000571	CcSEcCtD
Raloxifene—Nausea—Pamidronate—osteoporosis	6.32e-05	0.000564	CcSEcCtD
Raloxifene—Dizziness—Conjugated Estrogens—osteoporosis	6.19e-05	0.000552	CcSEcCtD
Raloxifene—Vomiting—Zoledronate—osteoporosis	6.18e-05	0.000551	CcSEcCtD
Raloxifene—Rash—Zoledronate—osteoporosis	6.13e-05	0.000547	CcSEcCtD
Raloxifene—Gastrointestinal pain—Estradiol—osteoporosis	6.12e-05	0.000547	CcSEcCtD
Raloxifene—Dermatitis—Zoledronate—osteoporosis	6.12e-05	0.000546	CcSEcCtD
Raloxifene—Headache—Zoledronate—osteoporosis	6.09e-05	0.000543	CcSEcCtD
Raloxifene—Vomiting—Conjugated Estrogens—osteoporosis	5.95e-05	0.000531	CcSEcCtD
Raloxifene—Body temperature increased—Estradiol—osteoporosis	5.92e-05	0.000528	CcSEcCtD
Raloxifene—Abdominal pain—Estradiol—osteoporosis	5.92e-05	0.000528	CcSEcCtD
Raloxifene—Rash—Conjugated Estrogens—osteoporosis	5.9e-05	0.000527	CcSEcCtD
Raloxifene—Dermatitis—Conjugated Estrogens—osteoporosis	5.89e-05	0.000526	CcSEcCtD
Raloxifene—Headache—Conjugated Estrogens—osteoporosis	5.86e-05	0.000523	CcSEcCtD
Raloxifene—Nausea—Zoledronate—osteoporosis	5.77e-05	0.000515	CcSEcCtD
Raloxifene—Nausea—Conjugated Estrogens—osteoporosis	5.56e-05	0.000496	CcSEcCtD
Raloxifene—Diarrhoea—Estradiol—osteoporosis	5.12e-05	0.000457	CcSEcCtD
Raloxifene—Dizziness—Estradiol—osteoporosis	4.95e-05	0.000442	CcSEcCtD
Raloxifene—Vomiting—Estradiol—osteoporosis	4.76e-05	0.000425	CcSEcCtD
Raloxifene—Rash—Estradiol—osteoporosis	4.72e-05	0.000421	CcSEcCtD
Raloxifene—Dermatitis—Estradiol—osteoporosis	4.72e-05	0.000421	CcSEcCtD
Raloxifene—Headache—Estradiol—osteoporosis	4.69e-05	0.000419	CcSEcCtD
Raloxifene—Nausea—Estradiol—osteoporosis	4.45e-05	0.000397	CcSEcCtD
Raloxifene—CYP19A1—Metabolism—MGLL—osteoporosis	2.21e-05	0.000811	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MGLL—osteoporosis	2.18e-05	0.000798	CbGpPWpGaD
Raloxifene—HTR2B—Class A/1 (Rhodopsin-like receptors)—POMC—osteoporosis	2.17e-05	0.000797	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CNR2—osteoporosis	2.17e-05	0.000795	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.16e-05	0.000792	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LRP5—osteoporosis	2.13e-05	0.000779	CbGpPWpGaD
Raloxifene—CYP2B6—Biological oxidations—POMC—osteoporosis	2.1e-05	0.000769	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—osteoporosis	2.1e-05	0.000768	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CALCR—osteoporosis	2.09e-05	0.000764	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTH1R—osteoporosis	2.09e-05	0.000764	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—WNT1—osteoporosis	2.04e-05	0.000747	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LRP6—osteoporosis	2.03e-05	0.000745	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PTHLH—osteoporosis	2.03e-05	0.000744	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PTHLH—osteoporosis	2.02e-05	0.000741	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MGLL—osteoporosis	1.99e-05	0.000729	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PKM—osteoporosis	1.98e-05	0.000725	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—FDPS—osteoporosis	1.98e-05	0.000725	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—CALCA—osteoporosis	1.96e-05	0.000718	CbGpPWpGaD
Raloxifene—EBP—Metabolism—POMC—osteoporosis	1.95e-05	0.000714	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—VDR—osteoporosis	1.94e-05	0.000712	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LRP5—osteoporosis	1.94e-05	0.000711	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—IDH2—osteoporosis	1.88e-05	0.00069	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	1.88e-05	0.000687	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PGLS—osteoporosis	1.88e-05	0.000687	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPD2—osteoporosis	1.88e-05	0.000687	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LRP6—osteoporosis	1.86e-05	0.00068	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—VDR—osteoporosis	1.86e-05	0.00068	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PTHLH—osteoporosis	1.85e-05	0.000676	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.84e-05	0.000673	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—POMC—osteoporosis	1.81e-05	0.000665	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—CYP19A1—osteoporosis	1.8e-05	0.000659	CbGpPWpGaD
Raloxifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.79e-05	0.000658	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—CALCA—osteoporosis	1.79e-05	0.000655	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—CALCA—osteoporosis	1.78e-05	0.000652	CbGpPWpGaD
Raloxifene—CYP2C8—Biological oxidations—POMC—osteoporosis	1.78e-05	0.000651	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP27A1—osteoporosis	1.77e-05	0.000648	CbGpPWpGaD
Raloxifene—AOX1—Disease—ADCY5—osteoporosis	1.75e-05	0.000643	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ACP5—osteoporosis	1.72e-05	0.000631	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TLN1—osteoporosis	1.72e-05	0.000629	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ATIC—osteoporosis	1.72e-05	0.000629	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PNP—osteoporosis	1.72e-05	0.000629	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.7e-05	0.000623	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—FDPS—osteoporosis	1.68e-05	0.000614	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PKM—osteoporosis	1.68e-05	0.000614	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MGLL—osteoporosis	1.66e-05	0.000607	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—POMC—osteoporosis	1.66e-05	0.000607	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—CALCA—osteoporosis	1.62e-05	0.000595	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LRP5—osteoporosis	1.62e-05	0.000593	CbGpPWpGaD
Raloxifene—AOX1—Disease—MTHFR—osteoporosis	1.61e-05	0.000591	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—TPI1—osteoporosis	1.6e-05	0.000586	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPD2—osteoporosis	1.59e-05	0.000582	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PGLS—osteoporosis	1.59e-05	0.000582	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.59e-05	0.000581	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TLN1—osteoporosis	1.57e-05	0.000575	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.56e-05	0.000573	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.55e-05	0.00057	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.55e-05	0.000568	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LRP6—osteoporosis	1.55e-05	0.000567	CbGpPWpGaD
Raloxifene—AOX1—Disease—IRS2—osteoporosis	1.53e-05	0.000562	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—MYC—osteoporosis	1.53e-05	0.000561	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—P4HB—osteoporosis	1.5e-05	0.000551	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—P4HB—osteoporosis	1.48e-05	0.000543	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GAPDH—osteoporosis	1.48e-05	0.000541	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ADCY5—osteoporosis	1.47e-05	0.000538	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—GPX1—osteoporosis	1.46e-05	0.000536	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—OXCT1—osteoporosis	1.46e-05	0.000534	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CA2—osteoporosis	1.46e-05	0.000534	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ATIC—osteoporosis	1.45e-05	0.000532	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PNP—osteoporosis	1.45e-05	0.000532	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.45e-05	0.000531	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTH—osteoporosis	1.44e-05	0.000528	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—RAP1A—osteoporosis	1.44e-05	0.000527	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MGLL—osteoporosis	1.42e-05	0.000521	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—ESR1—osteoporosis	1.42e-05	0.000519	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RAP1A—osteoporosis	1.42e-05	0.000519	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CNR2—osteoporosis	1.4e-05	0.000515	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IL6—osteoporosis	1.4e-05	0.000514	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—ADCY5—osteoporosis	1.39e-05	0.000511	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NFATC1—osteoporosis	1.38e-05	0.000506	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DKK1—osteoporosis	1.37e-05	0.000502	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—P4HB—osteoporosis	1.35e-05	0.000495	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—MTHFR—osteoporosis	1.35e-05	0.000495	CbGpPWpGaD
Raloxifene—AOX1—Disease—IRS1—osteoporosis	1.34e-05	0.000491	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—WNT1—osteoporosis	1.32e-05	0.000484	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PSMA5—osteoporosis	1.32e-05	0.000483	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—PSMA2—osteoporosis	1.32e-05	0.000483	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTH—osteoporosis	1.32e-05	0.000482	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TLN1—osteoporosis	1.31e-05	0.000479	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RAP1A—osteoporosis	1.29e-05	0.000474	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGA—osteoporosis	1.28e-05	0.000471	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CNR2—osteoporosis	1.28e-05	0.00047	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	1.28e-05	0.000468	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—ADCY5—osteoporosis	1.27e-05	0.000466	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—ADCY5—osteoporosis	1.27e-05	0.000464	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NFATC1—osteoporosis	1.26e-05	0.000462	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6R—osteoporosis	1.26e-05	0.000461	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.25e-05	0.00046	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DKK1—osteoporosis	1.25e-05	0.000458	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—OXCT1—osteoporosis	1.23e-05	0.000452	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CA2—osteoporosis	1.23e-05	0.000452	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—IDH2—osteoporosis	1.21e-05	0.000443	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—WNT1—osteoporosis	1.21e-05	0.000442	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MGLL—osteoporosis	1.2e-05	0.000441	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTHLH—osteoporosis	1.19e-05	0.000437	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—BMP2—osteoporosis	1.19e-05	0.000437	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—ESR2—osteoporosis	1.18e-05	0.000432	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGA—osteoporosis	1.17e-05	0.00043	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—FGB—osteoporosis	1.17e-05	0.000428	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ENO1—osteoporosis	1.16e-05	0.000426	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—ADCY5—osteoporosis	1.16e-05	0.000423	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PSMA2—osteoporosis	1.15e-05	0.00042	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PSMA5—osteoporosis	1.15e-05	0.00042	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP27A1—osteoporosis	1.14e-05	0.000416	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.13e-05	0.000416	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PSMA5—osteoporosis	1.13e-05	0.000413	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PSMA2—osteoporosis	1.13e-05	0.000413	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—P4HB—osteoporosis	1.13e-05	0.000413	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ACP5—osteoporosis	1.11e-05	0.000405	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTH—osteoporosis	1.1e-05	0.000401	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTHLH—osteoporosis	1.09e-05	0.000399	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—BMP2—osteoporosis	1.09e-05	0.000399	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—POMC—osteoporosis	1.08e-05	0.000396	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RAP1A—osteoporosis	1.08e-05	0.000395	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CNR2—osteoporosis	1.07e-05	0.000391	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—FGB—osteoporosis	1.07e-05	0.000391	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CALCA—osteoporosis	1.05e-05	0.000385	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NFATC1—osteoporosis	1.05e-05	0.000385	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DKK1—osteoporosis	1.04e-05	0.000382	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PSMA2—osteoporosis	1.03e-05	0.000377	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PSMA5—osteoporosis	1.03e-05	0.000377	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—TPI1—osteoporosis	1.03e-05	0.000377	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—POMC—osteoporosis	1.03e-05	0.000376	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—IDH2—osteoporosis	1.02e-05	0.000375	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—WNT1—osteoporosis	1e-05	0.000368	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGA—osteoporosis	9.77e-06	0.000358	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—P4HB—osteoporosis	9.66e-06	0.000354	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP27A1—osteoporosis	9.62e-06	0.000353	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CALCA—osteoporosis	9.6e-06	0.000352	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—KL—osteoporosis	9.55e-06	0.00035	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—POMC—osteoporosis	9.53e-06	0.000349	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GAPDH—osteoporosis	9.48e-06	0.000348	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ACP5—osteoporosis	9.36e-06	0.000343	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—POMC—osteoporosis	9.36e-06	0.000343	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—VDR—osteoporosis	9.35e-06	0.000343	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—POMC—osteoporosis	9.31e-06	0.000341	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.24e-06	0.000339	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—RAP1A—osteoporosis	9.24e-06	0.000338	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6R—osteoporosis	9.08e-06	0.000333	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—BMP2—osteoporosis	9.08e-06	0.000333	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTHLH—osteoporosis	9.08e-06	0.000333	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PKM—osteoporosis	8.99e-06	0.000329	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—FDPS—osteoporosis	8.99e-06	0.000329	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—FGB—osteoporosis	8.88e-06	0.000326	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—KL—osteoporosis	8.71e-06	0.000319	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—TPI1—osteoporosis	8.7e-06	0.000319	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PSMA2—osteoporosis	8.58e-06	0.000314	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PSMA5—osteoporosis	8.58e-06	0.000314	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPD2—osteoporosis	8.52e-06	0.000312	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PGLS—osteoporosis	8.52e-06	0.000312	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—POMC—osteoporosis	8.5e-06	0.000311	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6R—osteoporosis	8.29e-06	0.000304	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—P4HB—osteoporosis	8.18e-06	0.0003	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GAPDH—osteoporosis	8.03e-06	0.000294	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CALCA—osteoporosis	7.99e-06	0.000293	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—RAP1A—osteoporosis	7.82e-06	0.000287	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PNP—osteoporosis	7.8e-06	0.000286	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ATIC—osteoporosis	7.8e-06	0.000286	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MYC—osteoporosis	7.72e-06	0.000283	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ADCY5—osteoporosis	7.6e-06	0.000278	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—GPX1—osteoporosis	7.57e-06	0.000277	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ADCY5—osteoporosis	7.48e-06	0.000274	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ENO1—osteoporosis	7.47e-06	0.000274	CbGpPWpGaD
Raloxifene—AOX1—Disease—MYC—osteoporosis	7.46e-06	0.000273	CbGpPWpGaD
Raloxifene—AOX1—Disease—TGFB1—osteoporosis	7.44e-06	0.000273	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MYC—osteoporosis	7.37e-06	0.00027	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PSMA2—osteoporosis	7.36e-06	0.00027	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PSMA5—osteoporosis	7.36e-06	0.00027	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—KL—osteoporosis	7.26e-06	0.000266	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SPP1—osteoporosis	7.23e-06	0.000265	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—MTHFR—osteoporosis	6.99e-06	0.000256	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ADCY5—osteoporosis	6.83e-06	0.00025	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.82e-06	0.00025	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CA2—osteoporosis	6.63e-06	0.000243	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—OXCT1—osteoporosis	6.63e-06	0.000243	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SPP1—osteoporosis	6.6e-06	0.000242	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IRS2—osteoporosis	6.54e-06	0.00024	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MGLL—osteoporosis	6.46e-06	0.000237	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—LEP—osteoporosis	6.4e-06	0.000235	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ENO1—osteoporosis	6.32e-06	0.000232	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PSMA5—osteoporosis	6.23e-06	0.000228	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PSMA2—osteoporosis	6.23e-06	0.000228	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ESR1—osteoporosis	6.11e-06	0.000224	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS2—osteoporosis	5.97e-06	0.000219	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP19A1—osteoporosis	5.97e-06	0.000219	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—LEP—osteoporosis	5.84e-06	0.000214	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IRS1—osteoporosis	5.71e-06	0.000209	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ADCY5—osteoporosis	5.69e-06	0.000208	CbGpPWpGaD
Raloxifene—AOX1—Disease—IL6—osteoporosis	5.61e-06	0.000205	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—POMC—osteoporosis	5.59e-06	0.000205	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ESR1—osteoporosis	5.58e-06	0.000204	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SPP1—osteoporosis	5.5e-06	0.000202	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—POMC—osteoporosis	5.5e-06	0.000202	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—IDH2—osteoporosis	5.49e-06	0.000201	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6R—osteoporosis	5.37e-06	0.000197	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IGF1—osteoporosis	5.29e-06	0.000194	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS1—osteoporosis	5.21e-06	0.000191	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.16e-06	0.000189	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP19A1—osteoporosis	5.05e-06	0.000185	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ACP5—osteoporosis	5.02e-06	0.000184	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—POMC—osteoporosis	5.02e-06	0.000184	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS2—osteoporosis	4.97e-06	0.000182	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6R—osteoporosis	4.9e-06	0.000179	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ADCY5—osteoporosis	4.88e-06	0.000179	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—LEP—osteoporosis	4.87e-06	0.000178	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—GPX1—osteoporosis	4.86e-06	0.000178	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IGF1—osteoporosis	4.83e-06	0.000177	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—TPI1—osteoporosis	4.67e-06	0.000171	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—MTHFR—osteoporosis	4.49e-06	0.000164	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—P4HB—osteoporosis	4.39e-06	0.000161	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS1—osteoporosis	4.34e-06	0.000159	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GAPDH—osteoporosis	4.31e-06	0.000158	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—RAP1A—osteoporosis	4.2e-06	0.000154	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—POMC—osteoporosis	4.18e-06	0.000153	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ADCY5—osteoporosis	4.13e-06	0.000151	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—GPX1—osteoporosis	4.12e-06	0.000151	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6R—osteoporosis	4.08e-06	0.000149	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL6—osteoporosis	4.05e-06	0.000148	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IGF1—osteoporosis	4.02e-06	0.000147	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—MTHFR—osteoporosis	3.8e-06	0.000139	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—osteoporosis	3.72e-06	0.000136	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL6—osteoporosis	3.69e-06	0.000135	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—POMC—osteoporosis	3.59e-06	0.000131	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ENO1—osteoporosis	3.39e-06	0.000124	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PSMA2—osteoporosis	3.34e-06	0.000123	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PSMA5—osteoporosis	3.34e-06	0.000123	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—osteoporosis	3.18e-06	0.000116	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TGFB1—osteoporosis	3.17e-06	0.000116	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—POMC—osteoporosis	3.04e-06	0.000111	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—osteoporosis	2.9e-06	0.000106	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TGFB1—osteoporosis	2.9e-06	0.000106	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.71e-06	9.94e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—osteoporosis	2.42e-06	8.86e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TGFB1—osteoporosis	2.41e-06	8.84e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL6—osteoporosis	2.39e-06	8.76e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ADCY5—osteoporosis	2.22e-06	8.12e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—GPX1—osteoporosis	2.21e-06	8.09e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL6—osteoporosis	2.18e-06	7.99e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—MTHFR—osteoporosis	2.04e-06	7.47e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL6—osteoporosis	1.82e-06	6.66e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—POMC—osteoporosis	1.63e-06	5.97e-05	CbGpPWpGaD
